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Quality of life of a person with Parkinson’s disease and the relationship 
between the time of evolution and the severity of the disease
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Parkinson’s disease can cause disability and decrease the quality of life in its sufferers. The 
aim of this study was to evaluate the quality of life of a group of people with Parkinson’s 
disease and whether a relationship exists between time of evolution and severity of the 
disease. Secondary analysis was carried out on transversal data collected from 40 individuals 
with Parkinson’s disease registered in the Parkinson’s Association of Maringá, in Maringá-
PR-Brazil. Measures: three instruments were applied: a socio-demographic questionnaire, 
the Hoenh and Yahr Scale and the Parkinson’s Disease Questionnaire (PDQ-39). According 
to PDQ-39, men referred to a lower quality of life, although, statistically, there was no 
significant difference between the two genders. Differences were only observed in the 
dimensions of “activities of daily living” and “social support”, in which men presented 
higher impairment, and “emotions” and “bodily discomfort”, where women showed higher 
impairment. Furthermore, severity of disease tended to lead to a perception of lower 
quality of life regarding the dimensions of “activities of daily living” and “cognition”, which 
is relevant to improve clinical guidance and intervention.
Descriptors: Parkinson’s Disease; Chronic Disease; Quality of Life.
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Qualidade de vida de indivíduos com Parkinson e sua relação com 
tempo de evolução e gravidade da doença
A doença de Parkinson pode ser incapacitante e prejudicar a qualidade de vida de seus 
portadores. O objetivo do estudo foi avaliar a qualidade de vida de indivíduos com 
Parkinson e identificar relações com o tempo de evolução e gravidade da doença. Os 
dados foram coletados na cidade de Maringá, PR, Brasil, com 40 indivíduos cadastrados 
na Associação Maringaense de Parkinson, por meio da aplicação de três instrumentos: 
questionário sociodemográfico, escala de Hoenh e Yahr e PDQ-39. De acordo com o 
PDQ-39, os homens referiram pior qualidade de vida, embora sem diferenças estatísticas 
entre os sexos. Diferenças foram observadas apenas na dimensão “atividades de vida 
diária” e “apoio social”, com os homens apresentando maior acometimento e “bem-estar 
emocional” e “desconforto corporal”, com maior comprometimento entre as mulheres. 
Por outro lado, a gravidade da doença apresentou tendência a pior percepção na 
qualidade de vida nas dimensões atividades de vida diária e cognição, pontos relevantes 
para melhor orientação clínica e intervenção.
Descritores: Doença de Parkinson; Doença Crônica; Qualidade de Vida.
Calidad de vida de las personas con enfermedad de Parkinson y su 
relación con la evolución en el tiempo y la gravedad de la enfermedad
La enfermedad de Parkinson puede llegar a ser incapacitante y afectar a la calidad de 
vida de los pacientes. El objetivo de este estudio fue evaluar la calidad de vida de las 
personas con Parkinson e identificar las relaciones con el transcurso del tiempo y la 
gravedad de la enfermedad.  Los datos fueron recogidos en la ciudad de Maringá-PR-
Brasil, con 40 personas indexadas en la “Associação Maringaense de Parkinson”, a través 
de la aplicación de tres instrumentos: cuestionario sociodemográfico, escala de Hoenh 
e Yahr y PDQ-39. De acuerdo con el PDQ-39, los hombres reportaron peor calidad de 
vida, aunque no hubo diferencias estadísticas entre los sexos. Las diferencias apenas se 
observaron en la dimensión “actividades de vida diaria” y “apoyo social”, con los hombres 
presentando una mayor participación y “bienestar emocional” e “incomodidad física” con 
una más grave entre las mujeres. Por otra parte, la gravedad de la enfermedad mostró 
una tendencia a empeorar la percepción en la calidad de vida en las dimensiones de las 
actividades de la vida diaria y cognición, puntos importantes para una mejor orientación 
e intervención clínica.
Descriptores: Enfermedad de Parkinson; Enfermedad Cronica; Calidad de Vida.
Introduction
related to the quality of life(4). This takes place because 
the evolution of the disease causes an increase in 
limitations to perform activities of daily living (ADL)(1,5) 
combined with the appearance of cognitive dysfunction 
and bodily disorders, increasing the impact on the QoL, 
and including physical, psychological, emotional, social 
and economic aspects(2,6-7). Individuals with a chronic 
illness, such as Parkinson’s disease, must deal with 
physical discomfort as well as loss of social relationships, 
financial activities, work and leisure(8).
Parkinson’s disease (PD) is the second most 
prevalent neurodegenerative disease among the elderly, 
affecting 1 to 3% of this population(1-2). In Brazil, a study 
conducted in the state of Minas Gerais found that 3.3% 
of individuals over 65 years of age presented PD(3). 
Due to its progressive and chronic characteristics, the 
disease affects the quality of life (QoL) of patients. At 
the onset of the disease, the physical dimensions seem 
to be the most affected, since, initially, there are motor 
symptoms. However, as the disease progresses, there is 
a development of alterations involving other dimensions 
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Health related quality of life in patients with 
Parkinson´s disease is of key importance as new 
biopsychosocial models of medicine are adopted(9). The 
majority of PD studies focus on physical impairment 
and medication effects, aiming to obtain subsidies 
to improve the planning of therapeutic interventions 
directed toward these individuals(7,10), considering that 
the aim of therapy in patients with incurable chronic 
disorders, such as Parkinson´s disease, is to improve 
their quality of life(11). 
However, neuropsychiatric complications that 
include depression, anxiety, cognitive impairment 
and psychosis are very common(12).  All these factors 
influence the quality of life of the PD patient, so that 
they have an individual perception of their real chronic 
health condition and how it impacts on their quality of 
life(13). Therefore, the length time living with the disease 
may or may not predict the degree of impairment in the 
quality of life of the PD patient. 
It is important to identify those factors that 
most influence the quality of life of the PD patient, 
considering that these issues may not be evident 
upon clinical examination, not being part of the more 
common motor symptoms(9). Therefore, investigating 
the quality of life becomes crucial in order to understand 
the course of the disease and to seek strategies to 
promote the physical and psychic well-being of these 
individuals, thus improving the planning of therapeutic 
intervention directed toward them. Understanding these 
factors contributes to the knowledge and increases the 
commitment to quality of life which can better target the 
practice of nursing and of other professionals who work 
directly with patients and their families. 
Considering the above, this study aimed to evaluate 
the quality of life of individuals with PD and to identify 
whether a relationship exists between time of evolution 
and the disease severity.
Method
Data were collected  from March to June of 2008, 
in the city of Maringá – Paraná – Brazil, with Parkinson 
patients enrolled at the Parkinson’s Association of 
Maringá (PAM). This association is a civil, non-profit 
institution, created in 2004, the aim of which is to 
bring together and offer support to PD patients and 
their families. Monthly talks are given by Health 
Professionals, free speech therapy and physiotherapy is 
offered, along with other physical activities. Currently, 
the association has 50 PD patients enrolled, 40 of 
whom live in Maringá and the others in neighboring 
cities.  The inclusion criteria defined for this study 
were: to be a PD patient, enrolled in PAM and living 
in Maringá. The exclusion criterion was: to present 
another neurodegenerative related disease (dementia, 
neuropathies, among others). None of the individuals 
living in Maringá presented neurodegenerative related 
disease and, therefore, all 40 were included in the study. 
The study participants were evaluated individually, 
using three instruments:
1) a socio-demographic questionnaire, to collect 
data such as gender, age, ethnology, marital status, 
education level, time since diagnosis, disease progression 
time, current symptoms, presence of comorbities, and 
medication used for the treatment of PD, classified as 
dopamine, dopamine plus another anti-Parkinson drug 
and an anti-Parkinson drug only.  
2) the Hoenh and Yahr(14) Scale, which measures 
the severity of the disease according to the signs and 
symptoms presented. The researcher applies this scale 
from the observation of the eight stage clinical picture: 0 
(zero) for no sign of the disease; 1 for unilateral disease 
only; 1.5 for unilateral and axial impairment; 2 for 
bilateral disease, without impairment of equilibrium; 2.5 
for bilateral disease with mild impairment of equilibrium; 
3 for bilateral disease with mild and moderate impairment 
of equilibrium; 4 for severe disability, though capable of 
standing and walking without help and 5 for individuals 
in a wheelchair or confined to bed, in need of full help. 
For this study, the stages were grouped into three levels 
of impairment, defined as mild (0–2.0), moderate (2.5–
3.0) and severe (3.0–4.0)(15). 
3) PDQ-39 (Parkinson’s Disease Quality of Life 
Questionnaire) which is a specific questionnaire to 
measure the perception of quality of life of individuals 
with PD(16). It contains 39 questions divided into eight 
dimensions: mobility, activities of daily living, emotions, 
stigma, social support, cognition, communication and 
bodily discomfort. The questions refer to the frequency 
in which individuals have encountered difficult situations 
during the previous month, which is graded, by the 
interviewee, with scores from 0 (never) to 4 (always).
The overall score value or that of each dimension 
was obtained by using the following calculation:
sum of scores of each question within the dimension
4 (maximum score per question) X nº of questions within the dimension
X 100
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The score is a value from 0 to 100%, with the 
higher final score equating to the individual having a 
lower perception of his/her quality of life(5).
Data were organized in an Excel 2003 spreadsheet 
and analyzed using SPSS (Statistical Package for the 
Social Sciences), version 13.0 for Windows. According 
to the Kolmogorov-Smirnov test, all the variables 
presented normal distribution, except for the Hohen and 
Yahr Scale and the social support dimension of the PDQ-
39. For the evaluation of the hypothesis of difference 
among groups, the Student’s t test was used for the 
normally distributed variables, in order to compare 
the two independent groups and the ANOVA, following 
Bonferroni’s ad hoc test for multiple comparisons. 
However, for the variables that did not present normal 
distribution, the Mann-Whitney test was used in order 
to compare two independent groups, using p<0.05. 
The statistical descriptive analysis involved measures 
of central and dispersive tendencies (mean, median 
and standard deviation), for age, time since diagnosis, 
disease progression time and, if pertinent, the absolute 
and percentual frequencies.
The development of the study followed ethical 
principles according to resolution No. 196/96, of the 
National Health Council, and the project was approved 
by the Human Research Ethics Committee of Maringá 
State University (Protocol No. 438/2007). All the 
participants signed two copies of the Terms of Free Prior 
Informed Consent. 
Results
The sample consisted of 40 individuals with PD, the 
majority of whom were men (25) who presented a mean 
age of 65.1±9.9 years, being lower than the mean age of 
the women (66.0±11.6 years). The mean age at which 
participants received the diagnosis was 57.2±11.7 years, 
and the mean time of disease progression was 8.4±3.7 
years. Most of the study participants were married 
(30), white (32), with low levels of education – primary 
school (23), presented a moderate degree of disease 
impairment (28) and made use of dopamine (26). 
Details of clinical and socio-demographic characteristics 
are shown in Table 1. 
Table 1 - Clinical and socio-demographic characteristics 
of the study participants. Maringá, PR, Brazil, 2008
Variable n %
Gender
Male 25 62.5
Female 15 37.5
Ethnology
White 32 80.0
Black 5 12.5
Oriental 3 7.5
Marital Status
Married 30 75.0
Divorced 2 5.0
Widowed 7 17.5
Single 1 2.5
Education level
Incomplete Primary Education 22 55.0
Complete Primary Education 1 2.5
Incomplete High School Education 4 10.0
Complete High School Education 5 12.5
Incomplete Higher Education 1 2.5
Complete Higher Education 4 10.0
Illiterate 3 7.5
Disease impairment
Mild (0 – 2) 9 22.5
Moderate (2.5 – 3) 28 70.0
Severe (4 – 5) 3 7.5
Medication
Dopamine 5 12.5
Dopamine + another anti-Parkinson drug 21 52.5
Another anti-Parkinson drug 13 32.5
No treatment 1 2.5
Among the current signs and symptoms, 
bradykinesia was the most frequent and was referred to 
by 37 of the PD patients, followed by tremor and posture 
instability (35), and rigidity (29). Tremor may not have 
been the most prevalent symptom at the time, however, 
it was the first manifestation of the disease identified 
in the majority of cases (27). Other initial symptoms 
referred to by patients were slowness in ADL and in 
walking (7), fatigue and muscular weakness (4), and 
rigidity and lack of equilibrium (2). 
In comparing the two groups of male and female 
PD patients, although the male patients were found to 
be younger than the female patients, progression time 
and severity of the disease were higher in men.  This 
relationship, however, was not statistically confirmed. 
Statistical differences were observed in only four 
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Table 2 - Comparison between male and female PD 
patients, according to age, progression time, disease 
severity, PDQ-39 total score and dimension scores, 
Maringá, PR, Brazil, 2008
Table 3 - Comparison between PD patients of mild, 
moderate and severe impairment groups, according to 
the PDQ-39 and its dimensions. Maringá, PR, Brazil, 2008 
dimensions, with men being more affected in ADL and 
social support, while women were more affected in 
relation to emotions and bodily discomfort (Table 2). 
Men
n=25
Mean scores 
(SD)
Women
n=15
Mean scores 
(SD)
p value
Age 65.1±9.9 66.0±11.6 0.786
Progression time 8.8±3.7 7.7±3.4 0.378
Hoehn and Yahr 2.7±0.6 2.3±0.7 0.151
Total PDQ-39 35.9±12.4 34.7±17.8 0.808
Mobility 40.3±25.8 33.8±26.7 0.460
ADL 46.8±22.3 31.6±23.2 0.048*
Emotions 31.6±19.3 50.5±26.9 0.014*
Stigma 28.7±30.8 27.5±33.8 0.905
Social support 12.1±12.0 4.7±7.8 0.035*
Cognition 38.3±24.9 28.8±22.0 0.234
Communication 45.0±24.8 29.4±32.5 0.097
Bodily discomfort 33.6±17.5 54.4±29.8 0.008*
SD – standard deviation
*p<0.05
In Table 3, the mean scores for the PDQ-39 
dimensions were evaluated according to the different 
stages of the disease. This data shows that the quality 
of life of the PD individual is not affected by the stage 
of the disease and that the only dimensions affected 
by this variable are mobility, where the differences 
between the mild and severe groups were significant; 
and ADL and cognition, where the differences between 
the mild and severe groups were significant , as well 
as between those of moderate and severe impairment, 
which indicates a tendency for these aspects to worsen 
as the disease severity increases. 
Mild
n=9
Mean score 
(SD)
Moderate
n=28
Mean score
(SD)
Severe
n=3
Mean Score
(SD)
p value
F test
PDQ-39 30.1±14.2 35.5±14.0 51.5±9.6 0.084
Mobility 23.6±20.7 39.2±23.7 75.8±22.5 0.004*
ADL 22.4±18.1 41.7±19.7 76.3±20.9 0.005*†
Emotions 39.0±25.2 37.1±24.9 23.6±12.7 0.228
Stigma 19.5±25.5 30.8±31.4 4.1±7.2 0.392
Mild
n=9
Mean score 
(SD)
Moderate
n=28
Mean score
(SD)
Severe
n=3
Mean Score
(SD)
p value
F test
Social support 16.6±26.3 8.8±10.2 12.5±12.5 0.841
Cognition 30.4±23.2 30.5±21.0 83.3±3.6 0.000*†
Communication 29.1±26.7 42.0±28.8 58.3±8.3 0.127
Bodily discomfort 42.7±30.3 40.8±25.7 33.3±22.4 0.720
SD – standard deviation
*Indicates significant difference between the mild and severe impairment 
groups (p<0.05)
†Indicates significant difference between the moderate and severe 
impairment groups (p<0.05)
Discussion 
Parkinson’s disease is usually associated with the 
aging process, since the manifestation of signs and 
symptoms is associated with an 85-90% decrease of 
the dopamine concentration at the base ganglia(17). 
Therefore, the disease initiates long before its symptoms, 
the manifestations of which can be felt after 60-65 years 
of age(15,18). The study individuals felt the first signs and 
symptoms of the disease at approximately 60 years of 
age, and this could be one of the reasons to explain the 
delay/difficulty in establishing the diagnosis, considering 
that this stage of life concentrates manifestation of a 
great variety of chronic diseases. The majority of the 
individuals in this study were male, though the literature 
indicates no difference for incidence of the disease 
between the genders(18). However, a tendency of higher 
impairment among men has been registered(1-5,15,18), 
which is probably more related to cultural aspects. In 
India, for example, where a higher number of men were 
recorded among PD patients, the authors themselves 
attributed the fact to social and cultural contexts which 
prevent women from seeking health services(18).
In the present study, the higher proportion of 
men also appears to be a cultural matter associated 
with the site where the participants were enrolled 
– the Association. In such places, it is possible that 
the patients have been registered by members of the 
family, without necessarily participating in its activities. 
This kind of behavior matches the Brazilian pattern, 
since it is culturally accepted that the woman takes the 
responsibility for taking care of sick family members. 
This assumed responsibility makes them seek resources 
to aid the development of such care(19-20). Therefore, a 
considerable proportion of the male PD patients may 
have been enrolled by their wives. 
(continue...)
Table 3 - (continuation)
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The men presented greater time of disease 
progress, higher degree of impairment and worse 
perception of quality of life than the women, though 
there were no significant differences between the 
groups. The men were more affected in relation to 
ADL and social support, while the women were more 
affected regarding the emotions and bodily discomfort 
dimensions. These results are also consistent with the 
role of women in the Brazilian culture, since, although 
it is common that they take the responsibility when a 
member of the family gets sick(21), when it is them who 
need medical care, they hardly ever receive adequate 
support, and this makes them emotionally fragile. It is 
interesting to observe that although women presented 
lower mean scores of disease impairment, they have 
worse perceptions of bodily discomfort, which can be 
related to the fact that they continue to perform their 
home tasks. 
Regarding the group of men, it is worth noting 
their lower ability to handle limitations, pain, and lack of 
support. Furthermore, the fact that they usually conduct 
their activities outside the home, thus presenting limited 
skills for the performance of home tasks, may make 
them feel limited in general. Regarding the women, 
despite the reduction of the performance rhythm, they 
continue doing their usual activities. The simple fact that 
they keep developing activities related to housework 
allows them greater mobility for ADL(22). 
The impairment of the QoL happens very early, 
which can demonstrate a decrease in the first stages of 
the disease and worsen as severity increases(5). This fact 
was not found in this study, since, generally, no significant 
differences were observed between the values of the 
PDQ-39 and the degrees of impairment of the disease. 
Only the mobility dimension presented a difference 
between the mild and severe impairment groups, which 
indicates that a large increase in the manifestation of 
signs and symptoms is necessary for this to reflect in 
decreased mobility. Also, the activities of daily living and 
cognition dimensions presented differences between the 
mild and severe groups, and between the moderate and 
severe groups, indicating a greater sensitivity of these 
variables to small changes of signs and symptoms of the 
PD. It is interesting to observe that the motor symptoms 
were no longer exclusively considered the important 
determiners of QoL of the PD patients, but also the non-
motor ones, since the progression of the disease brings 
new alterations that certainly lead to the impairment 
of other QoL dimensions. The deterioration starts to be 
observed in the cognition, bodily discomfort, emotions 
and communication dimensions(5,9,23-24).
The severity of PD can have a higher impact on the 
quality of life, within the physical areas, mobility and ADL. 
However, the psychological adaptation to the disease, 
measured by indices of cognition, anxiety, depression, 
self-esteem, acceptance and attitude, is a contributing 
factor that also impacts directly on the QoL, as well as 
the severity of the disease(6). Conversely, a low level 
of psychological adaptation is more relevant than the 
severity of the disease for a worse QoL from the social 
perspective(6), since the impairment of motor abilities 
promotes a decrease in physical independence(2).
In the social dimension, there was no significant 
difference between the mild, moderate and severe 
groups. The social support and stigma dimensions 
can constantly present themselves as the disease 
progresses, due to the fact that there is an increase in 
the dissemination of information about PD and support 
by volunteers and groups(2). A greater impact of the 
chronic disease on quality of life was reported regarding 
the aspects of physical ability, activities of daily living 
and self-esteem(8), however, the social aspects cannot 
be ignored or be given less importance, because with 
the increase of the disabilities and limitations of daily 
living, a stigma can be created that can lead to social 
isolation.
The majority of the interviewees, 26 individuals, 
used dopamine, alone or associated with another anti-
Parkinson drug.  The dopaminergic drugs also have 
great influence on the PD patients QoL, considering their 
complications and adverse effects such as dizziness, 
motor fluctuations, dyskinesia, depression, among 
others(22), as well as their contribution to economic 
impairment. Research has shown that economic 
expenditure with PD is very high. The costs refer to 
hospitalization, medication and rehabilitation, as well as 
domestic costs, productivity loss, reduction of familiar 
income, and the early retirement of the individual(25). 
The low level of schooling of the patients is typical 
of the level of schooling of most Brazilian elderly(26). 
Although some authors believe that the low level of 
schooling can favor the QoL of individuals with PD, 
given the greater facility to accept the disease(2), we 
do not agree that access to information can negatively 
affect living with the disease, since it is progressive and 
incurable(2). On the contrary, educational and guidance 
programs are of extreme importance to improve the 
relationship with the disease, resulting in improvements 
in the QoL(25). 
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Conclusion
The results encountered permit a better 
comprehension of the influence of Parkinson’s disease 
on the quality of life of those who suffer from it, being 
that a better perception of the quality of life can produce 
positive effects in the health. Therefore, it is necessary 
to undertake efforts so that people with PD and their 
families can better exist with the disease. Thus, the 
results provide evidence that the performance of 
health professionals, particularly nurses, should focus 
on improving the quality of life with the consequent 
reduction of the impact of the disease. This can be 
achieved with greater proximity of the professionals, 
so that the care provided, including guidance and 
information regarding the disease, its evolution and 
forms of coping, correspond to the real needs of the 
patients and their families.
The fact that the men presented more time of 
evolution of the disease, a higher degree of impairment 
and a worse perception of the quality of life than the 
women, as well as greater impairment in relation to ADL 
and social support, while the women presented more 
bodily discomfort and had more emotional impairment, 
indicates the importance of an individualized approach. 
This approach must take into consideration and valorize, 
not only the needs presented, but also the important 
role of the family in the stimulation and socialization 
of these individuals, including the identification of the 
needs, potentials and fragilities of the family, for a more 
effective practice in partnership with them.
Finally, it is worth highlighting that the 
characteristics of the study sample, its limited size and 
that it originated from enrollment in an Association that 
aims to offer support for patients and their families, 
constitute limitations regarding the results found, which 
represent only trends that need to be confirmed or 
refuted. Therefore, further studies are necessary for the 
verification, or not, of differences between the genders, 
concerning behavior and disease evolution as well as the 
perception of quality of life.
References
1. Rodrigues de Paula F, Teixeira-Salmela LF, Faria CDCM, 
Brito PR, Cardoso F. Impact of an exercise program  on 
physical, emotional, and social aspects of quality of life 
of individuals with Parkinson´s disease. Mov Disord. 
2006;21(8):1073-7.
2. Souza RG, Borges V, Silva SMCA, Ferraz HB. Quality 
of life scale in Parkinson´s disease: PDQ-39 (Brazilian 
Portuguese version) to assess patients with and 
without levodopa motor fluctuation. Arq Neuropsiquiatr. 
2007;65(3-B):787-91.
3. Barbosa MT, Caramelli P, Maia DP, Cunningham 
MCQ, Guerra HLG, Lima-Costa MF. Parkinsonism and 
Parkinson´s disease in the elderly: a community-
based survey in Brazil (The Bambui study). Mov Disord. 
2006;21:800-8.
4. A`Campo LEI, Spliethoff-Kamminga NGA, Roos RAC. 
An evaluation of the patient education programme for 
Parkinson’s disease in clinical practice.   Int J Clin Pract. 
2011;65(11):1173-9.
5. Carod-Artal FJ, Vargas AP, Martinez-Martin P. 
Determinants of quality of life in brazilian patients with 
Parkinson´s Disease. Mov Disord. 2007;22(10):1408-15.
6. Suzukamo Y, Ohbu S, Kondo T, Kohmoto J, Fukuhara 
S. Psychological Adjustment Has a Greater Effect on 
Health-Related Quality of Life Than on Severity of Disease 
in Parkinson´s Disease. Mov Disord. 2006;21(6):761-6.
7. Knipe M, Wickremaratchi MM, Wyatt-Haines E, Morris 
HR, Ben-Shlomo Y. Quality of life in young- compared 
with late-onset Parkinson’s disease. MovDisord. 
2011;26(11):2011-8.
8. Martins LM, França APD, Kimura M. Quality of life of 
people with chronic illness. Rev. Latino-Am. Enfermagem. 
1996;4:5-18. 
9. Matinez-Martin P, Rodrigues-Blazquez C, Kurtis MM. 
The impact of non-motor symptoms on health-related 
quality of patients with Parkinson´s disease. Mov Disord. 
2011;6(3):399-407.
10. Duncan RP, Earhart GM. Measuring participation in 
individuals with Parkinson disease: relationships with 
disease severity, quality of life, and mobility. Disabil 
Rehabil. 2011;33(15-16):1440-6.
11. Gomez-Esteban JC, Tijero B, Somme J, Ciordia 
R, Berganzo K, Rouco I, et al. Impact of psychiatric 
symptoms and sleep disorders on the quality of 
life of patients with Parkinson´s disease.  J Neurol. 
2011;258(3):494-9.
12. Leroi I, Ahearn DJ, Andrews M, McDonald KR, Byrne 
EJ, Burns A. Behavioural disorders, disability and quality of 
life in Parkinson´s disease. Age Ageing. 2011;40:614-21.
13. Bucks RS, Cruise KE, Skinner TC, Loftus AM, Barker 
RA, Thomas MG. Coping processes and health-related 
quality of life in Parkinson´s disease. J Geriatr Psychiatry. 
2011;26:247-55.
391
www.eerp.usp.br/rlae
Navarro-Peternella FM, Marcon SS.
Received: Ago. 30th 2011
Accepted: Feb. 29th 2012
14. Hoehn, MM, Yahr MD. Parkinsonism: onset, 
progression and mortality. Neurology. 1967;17:427-42.
15. Li H, Zhang M, Chen L, Zhang J, Zhong P, Hu A et 
al. Nonmotor symptoms are independently associated 
with impaired heath-related quality of life in Chinese 
patients with Parkinson´s disease. Mov Disord. 
2010;25(16):2740-6.
16. Miyashita M, Narita Y, Sakamoto A, Kawada N, 
Akiyama M, Kayama M et al. Heath-related quality of 
life among community-dwelling patients with intractable 
neurological disease and their caregivers in Japan. 
Psychiatry Clin Neuroscien. 2011;65:30-8.
17. Lucas-Carrasco R, Pascual-Sedano B, Galán I, 
Kulisevsky J, Sastre-Garriga J, Gómez-Benito J. Using 
the WHOQOL-DIS to measure quality of life in persons 
with physical disabilities caused by neurodegenerative 
disorders. Neurodegener Dis. 2011;8(4):178-86.
18. Behari M, Srivastava AK, Pandey RM. Quality of life 
in patients with Parkinson´s disease. Parkinsonism Relat 
Disord. 2005;11:221-6. 
19. Simonetti JP, Ferreira JC. Estratégias de coping 
desenvolvidas por cuidadores de idosos portadores de 
doença crônica. Rev Esc Enferm USP. 2008;42(1):19-25. 
20. Peters M, Fitzpatrick R, Doll H, Playford D, Jenkinson 
C. Does self-reported well-being of patients with 
Parkinson’s disease influence caregiver strain and quality 
of life? Parkinsonism Related Disord. 2011;17(5):348-52.
21. Schestatsky P, Zanatto VC, Margis R, Chachamovitch 
E, Reche M, Batista G, et al. Quality of life in a Brazilian 
sample of patients with Parkinson´s disease and their 
caregivers. Rev Bras Psiquiatr. 2006;28(3):209-11.
22. Gómez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, 
Luna A, Velasco F, et al. Influence of motor symptoms 
upon the quality of life of patients with Parkinson´s 
disease. Eur Neurol. 2007;57:161-5. 
23. Grosset D, Taurah L, Burn DJ, MacMahon D, Forbes A, 
Turner K, et al. A multicentre longitudinal observational 
study of changes in self reported health status in people 
with Parkinson´s disease left untreated at diagnosis. J 
Neurol Neurosurg Psychiatry. 2007;78:465-9.
24. Schrag A, Hovris A, Morley D, Quinn  N, Jahanshahi 
M. Caregiver-burden in parkinson´s disease is closely 
associated with psychiatric symptoms, falls, and 
disability. Parkinsonism Relat Disord. 2006;12:35-41. 
25. Dowding CH, Shenton CL, Salek SS. A Review of 
the health-related quality of life and economic impact of 
Parkinson´s Disease. Drugs Aging. 2006;23(9):693-721.
26. IBGE. Pesquisa Nacional por Amostra de Domicílios 
(PNAD), 2007. [acesso 20 nov 2008]. Disponivel em: 
http://www.ibge.gov.br/home/estatistica/populacao/
contagem2007/default.shtm. 
